论文部分内容阅读
目的:探讨酒石酸美托洛尔治疗慢性心力衰竭的疗效观察。方法:回顾性分析2013年1月-2015年1月在我院入住的老年CHF患者70例的临床资料,随机分为对照组和观察组,对照组采取常规治疗,观察组在对照组的基础上实施酒石酸美托洛尔治疗,比较两组患者的临床疗效、血压、心率变化情况。结果:观察组总有效率为97.14%,对照组总有效率为85.71%,观察组临床疗效显著优于对照组,差异有显著性(p<0.05)。治疗后,观察组患者的收缩压、舒张压、心率显著低于对照组,差异有显著性(p<0.05)。结论:酒石酸美托洛尔治疗慢性心力衰竭疗效显著,可明显改善患者的心功能以及临床症状,提高患者的生活质量,值得临床推广使用。
Objective: To investigate the curative effect of metoprolol tartrate on chronic heart failure. Methods: The clinical data of 70 elderly CHF patients admitted to our hospital from January 2013 to January 2015 were retrospectively analyzed. The clinical data of 70 elderly patients with CHF were randomly divided into control group and observation group. The control group was treated routinely. The observation group was basal in the control group On the implementation of metoprolol tartrate treatment, the clinical efficacy of two groups were compared, blood pressure, heart rate changes. Results: The total effective rate was 97.14% in the observation group and 85.71% in the control group. The clinical efficacy of the observation group was significantly better than that of the control group (p <0.05). After treatment, systolic blood pressure, diastolic blood pressure and heart rate in observation group were significantly lower than those in control group (p <0.05). Conclusion: Metoprolol tartrate has significant therapeutic effect on chronic heart failure, which can significantly improve the patients’ cardiac function and clinical symptoms, and improve the quality of life of patients. It is worthy of clinical promotion.